PMC:7253482 / 2081-2334
Annnotations
LitCovid-PubTator
{"project":"LitCovid-PubTator","denotations":[{"id":"67","span":{"begin":100,"end":105},"obj":"Gene"}],"attributes":[{"id":"A67","pred":"tao:has_database_id","subj":"67","obj":"Gene:43740568"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"fective countermeasures to combat these pathogens. Ongoing vaccine development efforts focus on the spike (S) proteins that protrude from the viral envelope and constitute the main target of neutralizing antibodies7,8.\nThese trimeric S proteins mediate "}
LitCovid-PD-FMA-UBERON
{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T10","span":{"begin":110,"end":118},"obj":"Body_part"},{"id":"T11","span":{"begin":236,"end":244},"obj":"Body_part"}],"attributes":[{"id":"A10","pred":"fma_id","subj":"T10","obj":"http://purl.org/sig/ont/fma/fma67257"},{"id":"A11","pred":"fma_id","subj":"T11","obj":"http://purl.org/sig/ont/fma/fma67257"}],"text":"fective countermeasures to combat these pathogens. Ongoing vaccine development efforts focus on the spike (S) proteins that protrude from the viral envelope and constitute the main target of neutralizing antibodies7,8.\nThese trimeric S proteins mediate "}
LitCovid-PD-CLO
{"project":"LitCovid-PD-CLO","denotations":[{"id":"T11","span":{"begin":87,"end":92},"obj":"http://purl.obolibrary.org/obo/CLO_0009985"}],"text":"fective countermeasures to combat these pathogens. Ongoing vaccine development efforts focus on the spike (S) proteins that protrude from the viral envelope and constitute the main target of neutralizing antibodies7,8.\nThese trimeric S proteins mediate "}
LitCovid-PD-CHEBI
{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T10","span":{"begin":110,"end":118},"obj":"Chemical"},{"id":"T11","span":{"begin":236,"end":244},"obj":"Chemical"}],"attributes":[{"id":"A10","pred":"chebi_id","subj":"T10","obj":"http://purl.obolibrary.org/obo/CHEBI_36080"},{"id":"A11","pred":"chebi_id","subj":"T11","obj":"http://purl.obolibrary.org/obo/CHEBI_36080"}],"text":"fective countermeasures to combat these pathogens. Ongoing vaccine development efforts focus on the spike (S) proteins that protrude from the viral envelope and constitute the main target of neutralizing antibodies7,8.\nThese trimeric S proteins mediate "}
LitCovid-sample-PD-IDO
{"project":"LitCovid-sample-PD-IDO","denotations":[{"id":"T8","span":{"begin":40,"end":49},"obj":"http://purl.obolibrary.org/obo/IDO_0000528"}],"text":"fective countermeasures to combat these pathogens. Ongoing vaccine development efforts focus on the spike (S) proteins that protrude from the viral envelope and constitute the main target of neutralizing antibodies7,8.\nThese trimeric S proteins mediate "}
LitCovid-sample-Enju
{"project":"LitCovid-sample-Enju","denotations":[{"id":"T319","span":{"begin":8,"end":23},"obj":"NNS"},{"id":"T320","span":{"begin":24,"end":26},"obj":"TO"},{"id":"T321","span":{"begin":27,"end":33},"obj":"VB"},{"id":"T322","span":{"begin":34,"end":39},"obj":"DT"},{"id":"T323","span":{"begin":40,"end":49},"obj":"NNS"},{"id":"T324","span":{"begin":51,"end":58},"obj":"VBG"},{"id":"T325","span":{"begin":59,"end":66},"obj":"NN"},{"id":"T326","span":{"begin":67,"end":78},"obj":"NN"},{"id":"T327","span":{"begin":79,"end":86},"obj":"NNS"},{"id":"T328","span":{"begin":87,"end":92},"obj":"NN"},{"id":"T329","span":{"begin":93,"end":95},"obj":"IN"},{"id":"T330","span":{"begin":96,"end":99},"obj":"DT"},{"id":"T331","span":{"begin":100,"end":105},"obj":"NN"},{"id":"T332","span":{"begin":106,"end":107},"obj":"-LRB-"},{"id":"T333","span":{"begin":107,"end":108},"obj":"NN"},{"id":"T334","span":{"begin":108,"end":109},"obj":"-RRB-"},{"id":"T335","span":{"begin":110,"end":118},"obj":"NNS"},{"id":"T336","span":{"begin":119,"end":123},"obj":"WDT"},{"id":"T337","span":{"begin":124,"end":132},"obj":"VBP"},{"id":"T338","span":{"begin":133,"end":137},"obj":"IN"},{"id":"T339","span":{"begin":138,"end":141},"obj":"DT"},{"id":"T340","span":{"begin":142,"end":147},"obj":"JJ"},{"id":"T341","span":{"begin":148,"end":156},"obj":"NN"},{"id":"T342","span":{"begin":157,"end":160},"obj":"CC"},{"id":"T343","span":{"begin":161,"end":171},"obj":"VB"},{"id":"T344","span":{"begin":172,"end":175},"obj":"DT"},{"id":"T345","span":{"begin":176,"end":180},"obj":"JJ"},{"id":"T346","span":{"begin":181,"end":187},"obj":"NN"},{"id":"T347","span":{"begin":188,"end":190},"obj":"IN"},{"id":"T348","span":{"begin":191,"end":203},"obj":"VBG"},{"id":"T349","span":{"begin":204,"end":217},"obj":"NN"},{"id":"T350","span":{"begin":219,"end":224},"obj":"DT"},{"id":"T351","span":{"begin":225,"end":233},"obj":"JJ"},{"id":"T352","span":{"begin":234,"end":235},"obj":"NN"},{"id":"T353","span":{"begin":236,"end":244},"obj":"NNS"},{"id":"T354","span":{"begin":245,"end":252},"obj":"VBP"}],"relations":[{"id":"R316","pred":"arg1Of","subj":"T321","obj":"T320"},{"id":"R317","pred":"arg1Of","subj":"T319","obj":"T321"},{"id":"R318","pred":"arg2Of","subj":"T323","obj":"T321"},{"id":"R319","pred":"arg1Of","subj":"T323","obj":"T322"},{"id":"R320","pred":"arg1Of","subj":"T328","obj":"T324"},{"id":"R321","pred":"arg1Of","subj":"T328","obj":"T325"},{"id":"R322","pred":"arg1Of","subj":"T328","obj":"T326"},{"id":"R323","pred":"arg1Of","subj":"T328","obj":"T327"},{"id":"R324","pred":"arg1Of","subj":"T328","obj":"T329"},{"id":"R325","pred":"arg2Of","subj":"T335","obj":"T329"},{"id":"R326","pred":"arg1Of","subj":"T335","obj":"T330"},{"id":"R327","pred":"arg1Of","subj":"T335","obj":"T331"},{"id":"R328","pred":"arg1Of","subj":"T335","obj":"T332"},{"id":"R329","pred":"arg2Of","subj":"T333","obj":"T332"},{"id":"R330","pred":"arg3Of","subj":"T334","obj":"T332"},{"id":"R331","pred":"arg1Of","subj":"T335","obj":"T336"},{"id":"R332","pred":"arg1Of","subj":"T335","obj":"T337"},{"id":"R333","pred":"arg1Of","subj":"T337","obj":"T338"},{"id":"R334","pred":"arg2Of","subj":"T341","obj":"T338"},{"id":"R335","pred":"arg1Of","subj":"T341","obj":"T339"},{"id":"R336","pred":"arg1Of","subj":"T341","obj":"T340"},{"id":"R337","pred":"arg1Of","subj":"T337","obj":"T342"},{"id":"R338","pred":"arg2Of","subj":"T343","obj":"T342"},{"id":"R339","pred":"arg1Of","subj":"T335","obj":"T343"},{"id":"R340","pred":"arg2Of","subj":"T346","obj":"T343"},{"id":"R341","pred":"arg1Of","subj":"T346","obj":"T344"},{"id":"R342","pred":"arg1Of","subj":"T346","obj":"T345"},{"id":"R343","pred":"arg1Of","subj":"T346","obj":"T347"},{"id":"R344","pred":"arg2Of","subj":"T348","obj":"T347"},{"id":"R345","pred":"arg2Of","subj":"T349","obj":"T348"},{"id":"R346","pred":"arg1Of","subj":"T353","obj":"T350"},{"id":"R347","pred":"arg1Of","subj":"T353","obj":"T351"},{"id":"R348","pred":"arg1Of","subj":"T353","obj":"T352"},{"id":"R349","pred":"arg1Of","subj":"T353","obj":"T354"}],"text":"fective countermeasures to combat these pathogens. Ongoing vaccine development efforts focus on the spike (S) proteins that protrude from the viral envelope and constitute the main target of neutralizing antibodies7,8.\nThese trimeric S proteins mediate "}
LitCovid-sample-PD-FMA
{"project":"LitCovid-sample-PD-FMA","denotations":[{"id":"T10","span":{"begin":110,"end":118},"obj":"Body_part"},{"id":"T11","span":{"begin":236,"end":244},"obj":"Body_part"}],"attributes":[{"id":"A10","pred":"fma_id","subj":"T10","obj":"http://purl.org/sig/ont/fma/fma67257"},{"id":"A11","pred":"fma_id","subj":"T11","obj":"http://purl.org/sig/ont/fma/fma67257"}],"text":"fective countermeasures to combat these pathogens. Ongoing vaccine development efforts focus on the spike (S) proteins that protrude from the viral envelope and constitute the main target of neutralizing antibodies7,8.\nThese trimeric S proteins mediate "}
LitCovid-sample-CHEBI
{"project":"LitCovid-sample-CHEBI","denotations":[{"id":"T10","span":{"begin":110,"end":118},"obj":"Chemical"},{"id":"T11","span":{"begin":236,"end":244},"obj":"Chemical"}],"attributes":[{"id":"A10","pred":"chebi_id","subj":"T10","obj":"http://purl.obolibrary.org/obo/CHEBI_36080"},{"id":"A11","pred":"chebi_id","subj":"T11","obj":"http://purl.obolibrary.org/obo/CHEBI_36080"}],"text":"fective countermeasures to combat these pathogens. Ongoing vaccine development efforts focus on the spike (S) proteins that protrude from the viral envelope and constitute the main target of neutralizing antibodies7,8.\nThese trimeric S proteins mediate "}
LitCovid-sample-sentences
{"project":"LitCovid-sample-sentences","denotations":[{"id":"T15","span":{"begin":51,"end":218},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"fective countermeasures to combat these pathogens. Ongoing vaccine development efforts focus on the spike (S) proteins that protrude from the viral envelope and constitute the main target of neutralizing antibodies7,8.\nThese trimeric S proteins mediate "}
LitCovid-sample-Pubtator
{"project":"LitCovid-sample-Pubtator","denotations":[{"id":"67","span":{"begin":100,"end":105},"obj":"Gene"}],"attributes":[{"id":"A67","pred":"pubann:denotes","subj":"67","obj":"Gene:43740568"}],"text":"fective countermeasures to combat these pathogens. Ongoing vaccine development efforts focus on the spike (S) proteins that protrude from the viral envelope and constitute the main target of neutralizing antibodies7,8.\nThese trimeric S proteins mediate "}
LitCovid-sample-UniProt
{"project":"LitCovid-sample-UniProt","denotations":[{"id":"T714","span":{"begin":106,"end":118},"obj":"Protein"},{"id":"T747","span":{"begin":234,"end":244},"obj":"Protein"}],"attributes":[{"id":"A714","pred":"uniprot_id","subj":"T714","obj":"https://www.uniprot.org/uniprot/Q9UIP0"},{"id":"A715","pred":"uniprot_id","subj":"T714","obj":"https://www.uniprot.org/uniprot/Q9UIN9"},{"id":"A716","pred":"uniprot_id","subj":"T714","obj":"https://www.uniprot.org/uniprot/Q9UIN8"},{"id":"A717","pred":"uniprot_id","subj":"T714","obj":"https://www.uniprot.org/uniprot/Q9UIN7"},{"id":"A718","pred":"uniprot_id","subj":"T714","obj":"https://www.uniprot.org/uniprot/Q9UIN6"},{"id":"A719","pred":"uniprot_id","subj":"T714","obj":"https://www.uniprot.org/uniprot/Q9UBH8"},{"id":"A720","pred":"uniprot_id","subj":"T714","obj":"https://www.uniprot.org/uniprot/Q9NRH8"},{"id":"A721","pred":"uniprot_id","subj":"T714","obj":"https://www.uniprot.org/uniprot/Q9NRH7"},{"id":"A722","pred":"uniprot_id","subj":"T714","obj":"https://www.uniprot.org/uniprot/Q9NRH6"},{"id":"A723","pred":"uniprot_id","subj":"T714","obj":"https://www.uniprot.org/uniprot/Q9NRH5"},{"id":"A724","pred":"uniprot_id","subj":"T714","obj":"https://www.uniprot.org/uniprot/Q9NRH4"},{"id":"A725","pred":"uniprot_id","subj":"T714","obj":"https://www.uniprot.org/uniprot/Q9NPG5"},{"id":"A726","pred":"uniprot_id","subj":"T714","obj":"https://www.uniprot.org/uniprot/Q9NPE0"},{"id":"A727","pred":"uniprot_id","subj":"T714","obj":"https://www.uniprot.org/uniprot/Q9NP52"},{"id":"A728","pred":"uniprot_id","subj":"T714","obj":"https://www.uniprot.org/uniprot/Q95IF9"},{"id":"A729","pred":"uniprot_id","subj":"T714","obj":"https://www.uniprot.org/uniprot/Q8N5P3"},{"id":"A730","pred":"uniprot_id","subj":"T714","obj":"https://www.uniprot.org/uniprot/Q8IZU6"},{"id":"A731","pred":"uniprot_id","subj":"T714","obj":"https://www.uniprot.org/uniprot/Q8IZU5"},{"id":"A732","pred":"uniprot_id","subj":"T714","obj":"https://www.uniprot.org/uniprot/Q8IZU4"},{"id":"A733","pred":"uniprot_id","subj":"T714","obj":"https://www.uniprot.org/uniprot/Q86Z04"},{"id":"A734","pred":"uniprot_id","subj":"T714","obj":"https://www.uniprot.org/uniprot/Q7YR44"},{"id":"A735","pred":"uniprot_id","subj":"T714","obj":"https://www.uniprot.org/uniprot/Q7LA71"},{"id":"A736","pred":"uniprot_id","subj":"T714","obj":"https://www.uniprot.org/uniprot/Q7LA70"},{"id":"A737","pred":"uniprot_id","subj":"T714","obj":"https://www.uniprot.org/uniprot/Q5STD2"},{"id":"A738","pred":"uniprot_id","subj":"T714","obj":"https://www.uniprot.org/uniprot/Q5SQ85"},{"id":"A739","pred":"uniprot_id","subj":"T714","obj":"https://www.uniprot.org/uniprot/Q1XI16"},{"id":"A740","pred":"uniprot_id","subj":"T714","obj":"https://www.uniprot.org/uniprot/Q1XI12"},{"id":"A741","pred":"uniprot_id","subj":"T714","obj":"https://www.uniprot.org/uniprot/Q15517"},{"id":"A742","pred":"uniprot_id","subj":"T714","obj":"https://www.uniprot.org/uniprot/O43509"},{"id":"A743","pred":"uniprot_id","subj":"T714","obj":"https://www.uniprot.org/uniprot/O19084"},{"id":"A744","pred":"uniprot_id","subj":"T714","obj":"https://www.uniprot.org/uniprot/B0UYZ7"},{"id":"A745","pred":"uniprot_id","subj":"T714","obj":"https://www.uniprot.org/uniprot/B0S7V2"},{"id":"A746","pred":"uniprot_id","subj":"T714","obj":"https://www.uniprot.org/uniprot/A5A6L9"},{"id":"A747","pred":"uniprot_id","subj":"T747","obj":"https://www.uniprot.org/uniprot/Q9UIP0"},{"id":"A748","pred":"uniprot_id","subj":"T747","obj":"https://www.uniprot.org/uniprot/Q9UIN9"},{"id":"A749","pred":"uniprot_id","subj":"T747","obj":"https://www.uniprot.org/uniprot/Q9UIN8"},{"id":"A750","pred":"uniprot_id","subj":"T747","obj":"https://www.uniprot.org/uniprot/Q9UIN7"},{"id":"A751","pred":"uniprot_id","subj":"T747","obj":"https://www.uniprot.org/uniprot/Q9UIN6"},{"id":"A752","pred":"uniprot_id","subj":"T747","obj":"https://www.uniprot.org/uniprot/Q9UBH8"},{"id":"A753","pred":"uniprot_id","subj":"T747","obj":"https://www.uniprot.org/uniprot/Q9NRH8"},{"id":"A754","pred":"uniprot_id","subj":"T747","obj":"https://www.uniprot.org/uniprot/Q9NRH7"},{"id":"A755","pred":"uniprot_id","subj":"T747","obj":"https://www.uniprot.org/uniprot/Q9NRH6"},{"id":"A756","pred":"uniprot_id","subj":"T747","obj":"https://www.uniprot.org/uniprot/Q9NRH5"},{"id":"A757","pred":"uniprot_id","subj":"T747","obj":"https://www.uniprot.org/uniprot/Q9NRH4"},{"id":"A758","pred":"uniprot_id","subj":"T747","obj":"https://www.uniprot.org/uniprot/Q9NPG5"},{"id":"A759","pred":"uniprot_id","subj":"T747","obj":"https://www.uniprot.org/uniprot/Q9NPE0"},{"id":"A760","pred":"uniprot_id","subj":"T747","obj":"https://www.uniprot.org/uniprot/Q9NP52"},{"id":"A761","pred":"uniprot_id","subj":"T747","obj":"https://www.uniprot.org/uniprot/Q95IF9"},{"id":"A762","pred":"uniprot_id","subj":"T747","obj":"https://www.uniprot.org/uniprot/Q8N5P3"},{"id":"A763","pred":"uniprot_id","subj":"T747","obj":"https://www.uniprot.org/uniprot/Q8IZU6"},{"id":"A764","pred":"uniprot_id","subj":"T747","obj":"https://www.uniprot.org/uniprot/Q8IZU5"},{"id":"A765","pred":"uniprot_id","subj":"T747","obj":"https://www.uniprot.org/uniprot/Q8IZU4"},{"id":"A766","pred":"uniprot_id","subj":"T747","obj":"https://www.uniprot.org/uniprot/Q86Z04"},{"id":"A767","pred":"uniprot_id","subj":"T747","obj":"https://www.uniprot.org/uniprot/Q7YR44"},{"id":"A768","pred":"uniprot_id","subj":"T747","obj":"https://www.uniprot.org/uniprot/Q7LA71"},{"id":"A769","pred":"uniprot_id","subj":"T747","obj":"https://www.uniprot.org/uniprot/Q7LA70"},{"id":"A770","pred":"uniprot_id","subj":"T747","obj":"https://www.uniprot.org/uniprot/Q5STD2"},{"id":"A771","pred":"uniprot_id","subj":"T747","obj":"https://www.uniprot.org/uniprot/Q5SQ85"},{"id":"A772","pred":"uniprot_id","subj":"T747","obj":"https://www.uniprot.org/uniprot/Q1XI16"},{"id":"A773","pred":"uniprot_id","subj":"T747","obj":"https://www.uniprot.org/uniprot/Q1XI12"},{"id":"A774","pred":"uniprot_id","subj":"T747","obj":"https://www.uniprot.org/uniprot/Q15517"},{"id":"A775","pred":"uniprot_id","subj":"T747","obj":"https://www.uniprot.org/uniprot/O43509"},{"id":"A776","pred":"uniprot_id","subj":"T747","obj":"https://www.uniprot.org/uniprot/O19084"},{"id":"A777","pred":"uniprot_id","subj":"T747","obj":"https://www.uniprot.org/uniprot/B0UYZ7"},{"id":"A778","pred":"uniprot_id","subj":"T747","obj":"https://www.uniprot.org/uniprot/B0S7V2"},{"id":"A779","pred":"uniprot_id","subj":"T747","obj":"https://www.uniprot.org/uniprot/A5A6L9"}],"text":"fective countermeasures to combat these pathogens. Ongoing vaccine development efforts focus on the spike (S) proteins that protrude from the viral envelope and constitute the main target of neutralizing antibodies7,8.\nThese trimeric S proteins mediate "}
LitCovid-sentences
{"project":"LitCovid-sentences","denotations":[{"id":"T15","span":{"begin":51,"end":218},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"fective countermeasures to combat these pathogens. Ongoing vaccine development efforts focus on the spike (S) proteins that protrude from the viral envelope and constitute the main target of neutralizing antibodies7,8.\nThese trimeric S proteins mediate "}